Versant Capital Management, Inc - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 4 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$4,0001,091
+1374.3%
0.00%
Q1 2019$074
-37.8%
0.00%
Q4 2018$0119
+60.8%
0.00%
Q3 2018$074
+208.3%
0.00%
Q1 2018$0240.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders